000 01463 a2200445 4500
005 20250515193945.0
264 0 _c20100430
008 201004s 0 0 eng d
022 _a1776-260X
024 7 _a10.1007/s11523-009-0124-y
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCapdevila, Jaume
245 0 0 _aTargeted therapies in thyroid cancer.
_h[electronic resource]
260 _bTargeted oncology
_cDec 2009
300 _a275-85 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aCarcinoma, Papillary
_xdrug therapy
650 0 4 _aCell Line, Tumor
650 0 4 _aCell Transformation, Neoplastic
650 0 4 _aDisease Models, Animal
650 0 4 _aDrug Delivery Systems
_xmethods
650 0 4 _aDrug Design
650 0 4 _aGenes, ras
_xgenetics
650 0 4 _aHumans
650 0 4 _aMice
650 0 4 _aMice, Nude
650 0 4 _aNeoplasm Recurrence, Local
650 0 4 _aNeoplasm Transplantation
650 0 4 _aProtein Kinase Inhibitors
_xadministration & dosage
650 0 4 _aProto-Oncogene Proteins c-ret
_xgenetics
650 0 4 _aRats
650 0 4 _aThyroid Neoplasms
_xgenetics
650 0 4 _aXenograft Model Antitumor Assays
700 1 _aPerez-Garcia, Jose
700 1 _aObiols, Gabriel
700 1 _aTabernero, Josep
773 0 _tTargeted oncology
_gvol. 4
_gno. 4
_gp. 275-85
856 4 0 _uhttps://doi.org/10.1007/s11523-009-0124-y
_zAvailable from publisher's website
999 _c19291418
_d19291418